[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650548":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":10,"centralContacts":24,"locations":30,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":10,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Fundacion SEIMC-GESIDA","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Arm of colonized patients",null,"All the patients entering the ICU colonized by a microorganism",[13],"Drug: Standard of care therapy",{"label":15,"type":10,"description":16,"interventionNames":17},"Control Arm","All the patients entering the ICU not colonized by a microorganism",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"DRUG","Standard of care therapy","This is an observational study. Patients receive standard of care therapy as part of routine clinical practice according to the physician's discretion. No experimental intervention is assigned by the protocol.",[9,15],[25],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Montserrat Aguirregabiria, Principal Investigator","CONTACT","034687428599","montseara17@gmail.com",[31],{"facility":32,"status":33,"city":34,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Hospital Universitario La Paz","RECRUITING","Madrid","28046","Spain","ES",{"type":39,"coordinates":40},"Point",[41,42],-3.70256,40.4165,{"lat":42,"lon":41},[45],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100650548","gram-negatives-study-100650548",false,"NCT07749508","GRAM NEGATIVES STUDY","Design of a Predictive Model of Mortality in Critically Ill Patients Colonized by Multiresistant Gram-negative Bacteria. MR-GEIPC STUDY","MR-GEIPC","Inclusion Criteria:\n\n* Patients aged ≥18 years\n* Have given informed consent.\n\nExclusion Criteria:\n\n* Patients who do not agree to participate in the study\n* Admission to the ICU \\\u003C 24 hours","ALL",{"count":58,"type":59},1500,"ESTIMATED","OBSERVATIONAL","This is a prospective, observational, multicenter study whose main objective is to develop a predictive model of mortality in critically ill patients colonized by multidrug-resistant Gram-negative bacteria (MDR-GNB).\n\nSecondary objectives include: determining the characteristics of patients colonized by MRGB who require admission or acquire colonization during their stay in an intensive care unit (ICU); studying the infectious complications they develop, their etiology, clinical impact, and prognosis.",[63],"Multi-resistant Gram-negative Bacteria Cause Infection",[65,66,67,68,69,70,71,72,73,74,75,76],"Intensive Care Unit","Critical Patients","Multidrug Resistant Bacteria","Fungical infections","Viral infections","Gram-negative colonization","Focus of infection","Sequential Organ Failure Assessment","Gram-Negatives","Increment score","Charlson index","Glasgow coma scale","2026-08-05",{"date":79,"type":80},"2026-08-06","ACTUAL",{"date":82,"type":80},"2026-03-02",{"date":84,"type":59},"2027-05-31",{"name":5,"class":6},1]